These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 3561111
21. A call to action. Shepherd J. Eur Heart J; 1998 Oct; 19 Suppl M():M2-7. PubMed ID: 9821010 [Abstract] [Full Text] [Related]
22. [Heparin in the pathogenesis, prevention and therapy of ischemic heart disease]. Riecanský I, Kusá O, Luknárová O, Haviar V. Vnitr Lek; 1983 May; 29(5):439-45. PubMed ID: 6880060 [No Abstract] [Full Text] [Related]
23. [Primary and secondary prevention of the acute coronary syndrome]. Weingärtner O, Laufs U. Hamostaseologie; 2006 May; 26(2):158-66; quiz 167-8. PubMed ID: 16676060 [Abstract] [Full Text] [Related]
24. [Joint recommendations of Israel medical societies for prevention of coronary heart disease and atherosclerosis]. Harats D, Rubinstein A. Harefuah; 2000 Jan 02; 138(1):66-74. PubMed ID: 10868184 [No Abstract] [Full Text] [Related]
25. Geographic variations in coronary heart disease. A perspective on risk factors and prevention. Thind IS. Adv Myocardiol; 1980 Jan 02; 2():527-44. PubMed ID: 6999565 [Abstract] [Full Text] [Related]
26. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. EUROASPIRE II Study Group. Eur Heart J; 2001 Apr 02; 22(7):554-72. PubMed ID: 11259143 [Abstract] [Full Text] [Related]
27. [Statins in primary prevention of coronary heart disease]. Paulweber B. Wien Med Wochenschr; 1999 Apr 02; 149(5-6):129-38. PubMed ID: 10408004 [Abstract] [Full Text] [Related]
30. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations]. Idzior-Waluś B. Przegl Lek; 1999 Apr 02; 56(5):372-6. PubMed ID: 10554575 [Abstract] [Full Text] [Related]
31. Cardiovascular prevention in patients with diabetes and prediabetes. Anselmino M, Gohlke H, Mellbin L, Rydén L. Herz; 2008 Apr 02; 33(3):170-7. PubMed ID: 18568310 [Abstract] [Full Text] [Related]
32. [Primary prevention of ischemic heart disease. A review on the intervention survey]. Brendstrup T, Mørck HI. Ugeskr Laeger; 1980 Jan 14; 142(3):191-6. PubMed ID: 7355497 [No Abstract] [Full Text] [Related]
33. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D, TASPIC-CRO Study Group Investigators. Eur J Cardiovasc Prev Rehabil; 2006 Aug 14; 13(4):646-54. PubMed ID: 16874158 [Abstract] [Full Text] [Related]
34. [Evidence-based medicine in cardiology with an example of secondary prevention of coronary heart disease]. Gohlke H. Z Arztl Fortbild Qualitatssich; 1999 Aug 14; 93(6):403-7. PubMed ID: 10519189 [Abstract] [Full Text] [Related]
35. [Secondary prevention of coronary disease in France. Result of the EUROASPIRE study: the Lille register of ischemic cardiopathies]. Montaye M, Richard F, Lemaire B, Domanievitcz RM, Lenoir MF, Danet S, Amouyel P. Arch Mal Coeur Vaiss; 1998 Oct 14; 91(10):1211-20. PubMed ID: 9833084 [Abstract] [Full Text] [Related]
36. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur Heart J; 1987 Jan 14; 8(1):77-88. PubMed ID: 3816842 [Abstract] [Full Text] [Related]
37. [Why the cardiologists should be interested in lipids?]. López-Sendón JL, Rubio R, López de Sá E, Delcán JL. Rev Esp Cardiol; 1995 Jan 14; 48 Suppl 2():23-32. PubMed ID: 7569272 [Abstract] [Full Text] [Related]